Robert Beardsley
Founder at GALERA THERAPEUTICS, INC.
Net worth: 22 396 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Chris Degnan | M | 44 | 5 years | |
| Jennifer Stacey | F | 59 | 3 years | |
| Michael Powell | M | 69 | 8 years | |
| J. Sorensen | M | 67 | 12 years | |
| Dennis P. Riley | M | - |
Galera Therapeutics LLC
 Galera Therapeutics LLC Medical/Nursing ServicesHealth Services Galera Therapeutics LLC provides and develops drugs. The firm is dedicated to the development of innovative, effective and safe medicines to treat cancer and prevent the side effects associated with current treatment regimens. Galera Therapeutics was founded in 2009 and is headquartered in St. Louis, MO. | 15 years |
| Kevin Lokay | M | 67 | 5 years | |
| Linda West | F | 64 | 4 years | |
| Lawrence Alleva | M | 74 | 5 years | |
| Angeline K. Shashlo | F | - |
Metabolic Solutions Development Co. LLC
 Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | 15 years |
| Emmett Cunningham | M | 63 | 6 years | |
| Andie Collier | F | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Joel F. Sussman | M | 75 | - | |
| Randy W. Weiss | M | - | - | |
| Andrew Powell | M | 66 |
CollaGenex Pharmaceuticals, Inc.
 CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | 4 years |
| Alan Dunton | M | 70 |
Metaphore Pharmaceuticals, Inc.
 Metaphore Pharmaceuticals, Inc. BiotechnologyHealth Technology Metaphore Pharmaceuticals, Inc. is a pharmaceutical company which discovers, develops and markets drugs that prevent and treat pain, autoimmune disorders and inflammation. The company leverages its expertise in chemistry and biology to discover and develop small molecule compounds that mimic the activity of human enzymes. The company's compounds mimic the function of superoxide dismutase (SOD), a beneficial enzyme that serves an important protective role in the body by removing superoxide, a toxic free radical that can damage cells and tissues. Superoxide anions are implicated in a variety of diseases associated with pain and inflammation. The company is headquartered in St. Louis, MO. | 3 years |
| Jason Fuller | M | 46 | - | |
| Thomas Dyrberg | M | 69 | - | |
| Campbell Murray | M | 48 | 7 years | |
| George Lasezkay | M | 72 |
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | 3 years |
| Phillip M. Buckler | M | - |
Metaphore Pharmaceuticals, Inc.
Metaphore Pharmaceuticals, Inc. BiotechnologyHealth Technology Metaphore Pharmaceuticals, Inc. is a pharmaceutical company which discovers, develops and markets drugs that prevent and treat pain, autoimmune disorders and inflammation. The company leverages its expertise in chemistry and biology to discover and develop small molecule compounds that mimic the activity of human enzymes. The company's compounds mimic the function of superoxide dismutase (SOD), a beneficial enzyme that serves an important protective role in the body by removing superoxide, a toxic free radical that can damage cells and tissues. Superoxide anions are implicated in a variety of diseases associated with pain and inflammation. The company is headquartered in St. Louis, MO. | - |
| Henning Thorsen | M | - | - | |
| Eugene Kennedy | M | 55 | 1 years | |
| Jeffery Keene | M | - |
Galera Therapeutics LLC
Galera Therapeutics LLC Medical/Nursing ServicesHealth Services Galera Therapeutics LLC provides and develops drugs. The firm is dedicated to the development of innovative, effective and safe medicines to treat cancer and prevent the side effects associated with current treatment regimens. Galera Therapeutics was founded in 2009 and is headquartered in St. Louis, MO. | - |
| Christopher Powala | M | 64 |
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | 15 years |
| Frank Ruffo | M | 58 |
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | 12 years |
| Arthur Fratamico | M | 58 | - | |
| Frank Torti | M | 45 | - | |
| Henry Skinner | M | 60 | - | |
| Jon T. Holmlund | M | 67 | 10 years | |
| Michael Barrett | M | 81 | - | |
| Colin W. Stewart | M | 72 |
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | 5 years |
| Catherine Matthes | F | - |
Galera Therapeutics LLC
Galera Therapeutics LLC Medical/Nursing ServicesHealth Services Galera Therapeutics LLC provides and develops drugs. The firm is dedicated to the development of innovative, effective and safe medicines to treat cancer and prevent the side effects associated with current treatment regimens. Galera Therapeutics was founded in 2009 and is headquartered in St. Louis, MO. | - |
| Robert A. Medv | M | 58 |
Metaphore Pharmaceuticals, Inc.
Metaphore Pharmaceuticals, Inc. BiotechnologyHealth Technology Metaphore Pharmaceuticals, Inc. is a pharmaceutical company which discovers, develops and markets drugs that prevent and treat pain, autoimmune disorders and inflammation. The company leverages its expertise in chemistry and biology to discover and develop small molecule compounds that mimic the activity of human enzymes. The company's compounds mimic the function of superoxide dismutase (SOD), a beneficial enzyme that serves an important protective role in the body by removing superoxide, a toxic free radical that can damage cells and tissues. Superoxide anions are implicated in a variety of diseases associated with pain and inflammation. The company is headquartered in St. Louis, MO. | 3 years |
| Robert Easton | M | 78 |
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | 15 years |
| Peter R. Barnett | M | 72 |
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | 11 years |
| David F. Pfeiffer | M | 61 |
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | 11 years |
| Nancy C. Broadbent | F | 68 |
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | 12 years |
| Robert C. Black | M | 81 |
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | 9 years |
| Klaus P. J. Theobald | M | 68 |
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | 4 years |
| Mark Bachleda | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 40 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Robert Beardsley
- Personal Network